Vos C M, Westera G, van der Jagt P J, van Zanten B
Eur J Nucl Med. 1979 Oct;4(5):393-6. doi: 10.1007/BF00263311.
Dose loading effects upon the performance of 57Co-bleomycin as a tumor localizing agent have been investigated in Rhabdomyosarcoma bearing Wag/Ry rats. The addition of non-radioactively labelled Co-bleomycin increased the relative uptake of 57Co-bleomycin in rapid growing tumors, but the addition of non-chelated bleomycin had no influence at all. In our experimental system, iodinated bleomycin generally labelled by reaction with ICl, was found to be an unsatisfactory tumor localizing agent. In order to combine the useful localizing properties of Co-bleomycin with the qualified detection properties of some iodine isotopes, we attempted to prepare bleomycin doubly labelled with Co and I. However, we were unable to prepare 57Co-125I-bleomycin by general labelling with ICl. This result indicates that both labels need the imidazole ring for the formation of a stable, labelled bleomycin.
在携带横纹肌肉瘤的Wag/Ry大鼠中,研究了剂量加载对57Co-博来霉素作为肿瘤定位剂性能的影响。添加非放射性标记的钴-博来霉素可增加快速生长肿瘤中57Co-博来霉素的相对摄取,但添加非螯合的博来霉素则完全没有影响。在我们的实验系统中,通常通过与ICl反应标记的碘化博来霉素被发现是一种不理想的肿瘤定位剂。为了将钴-博来霉素有用的定位特性与某些碘同位素合格的检测特性相结合,我们尝试制备钴和碘双重标记的博来霉素。然而,我们无法通过用ICl进行常规标记来制备57Co-125I-博来霉素。这一结果表明,两种标记都需要咪唑环来形成稳定的标记博来霉素。